CN1586506A - Jiangbai oral liquid - Google Patents
Jiangbai oral liquid Download PDFInfo
- Publication number
- CN1586506A CN1586506A CN 200410050165 CN200410050165A CN1586506A CN 1586506 A CN1586506 A CN 1586506A CN 200410050165 CN200410050165 CN 200410050165 CN 200410050165 A CN200410050165 A CN 200410050165A CN 1586506 A CN1586506 A CN 1586506A
- Authority
- CN
- China
- Prior art keywords
- radix
- olibanum
- myrrha
- angelicae sinensis
- flos lonicerae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides an oral liquid for treating leucocytosis caused by leukemia. It is one kind of Chinese medicine preparation prepared with Dangshen, honey locust spine, angelica, indigo, frankincense and other seven kinds of Chinese medicinal materials. It is suitable for treating leucocytosis caused by leukemia, and has high curative effect, convenient taking and no toxic side effect.
Description
The present invention is a kind of medicine that leukemia causes that leukocyte increases for the treatment of, be to be the Chinese medicine preparation that raw material is made, the invention still further relates to the preparation method of this medicine by Radix Codonopsis, dense lucky, Spina Gleditsiae, Radix Angelicae Sinensis, Indigo Naturalis, Olibanum, Myrrha, Radix Trichosanthis, Flos Lonicerae, the Rhizoma Anemarrhenae, Cortex Lycii, Cornu Saigae Tataricae powder.
More existing treatment leukemia cause that leukocyte increases the medicine of disease, all has such or such deficiency.
The object of the present invention is to provide a kind of leukemia for the treatment of to cause that leukocyte increases the medicine of disease, through clinical verification for many years, evident in efficacy.
Solution of the present invention is according to medicine principle, through clinical experience for many years, and according to the theory of Chinese medical science prescription, each herbal medicine synergism, but nourishing YIN to lower pathogenic fire, remove the bone marrow excess-heat, to reach curative effect.
Prescription of the present invention is formed: Radix Codonopsis 30g, Herba Crotalariae sessiliflorae 30g, Spina Gleditsiae 30g, Radix Angelicae Sinensis 15g, Indigo Naturalis 30g, Olibanum 15g, Myrrha 15g, Radix Trichosanthis 30g, Flos Lonicerae 30g, Rhizoma Anemarrhenae 30g, Cortex Lycii 30g, Cornu Saigae Tataricae powder 30g.
Compound basis of the present invention:
Radix Codonopsis: contain chemical constituents such as Saponin, inulin, alnulin, brown sour methyl ester, methyl caprylate.The flat sweet in the mouth of property." main invigorating the spleen and replenishing QI, and taste, relieving thirst and restlessness a little less than the middle feeble QI, are mended in order to transfer, and be very smooth and proper " " Bencao Congxin ".
Dense lucky: contain chemical constituents such as dense lucky first element (monocrotaline), dense lucky second element, dense lucky third element, property is flat, bitter in the mouth is hot.Effect: suppressing the hyperactive liver vegetables liver, dispelling pathogenic wind for improving eyesight.
Spina Gleditsiae: contain flavonoid glycoside, leucocyanidin, chemical constituents such as fustin.Warm in nature, acrid in the mouth.Dense, the pain that disappears of invigorating blood circulation of function poison holding row.
Radix Angelicae Sinensis: contain chemical constituents such as n-butene base Phthalide, carvacrol, Ligustilide, o-cresol.Sweet in the mouth warm in nature, suffering.Function is invigorated blood circulation, pain relieving.
Indigo Naturalis: contain chemical constituents such as indigo, indirubin, qingdainone, couroupitine A, Indigo Naturalis element.Cold in nature, salty in the mouth.Effect: heat-clearing and toxic substances removing, removing heat from blood looses swollen.
Olibanum: contain boswellic acid, chemical constituents such as olibanoresene, acrid in the mouth warm in nature, hardship.Effect: regulating qi and activating blood, analgesic therapy, removing toxic substances and promoting subsidence of swelling.
Myrrha: contain chemical constituents such as commiphorinic acid, commiferin.The property flat, bitter in the mouth." incised wound is treated in the removing blood stasis pain relieving, flogging injury, and all malignant boil, skin ulcer is leaked " " Kaibao Bencao "." Olibanum is invigorated blood circulation, and the Myrrha blood that looses all can pain relieving, and detumescence and promoting granulation is used so two medicines are often held concurrently mutually " Compendium of Material Medica.
Radix Trichosanthis: contain division albumen, THFPS, draw together chemical constituents such as building root polysaccharide, lectins, cold in nature, bitter in the mouth, little sweet.Clearing away heat and promoting production of body fluid, row is dense in detumescence.
Flos Lonicerae: contain chemical constituents such as linalool, geraniol, this rhinoceros grass element, chlorogenic acid, isochlorogenic acid.Cold in nature, sweet in the mouth.Main heat-clearing and toxic substances removing.
The Rhizoma Anemarrhenae: contain chemical constituents such as zhimusaponin, chinaroot greenbrier sapogenin, Mengiferin, lignanoid.Cold in nature, bitter in the mouth, sweet.Main clearing away heat-fire is nourshing Yin and drynsessmoistening prescription.
Cortex Lycii: contain chemical constituents such as cinnamic acid, Radix Betae acid, β-sitosterol.Cold in nature, sweet in the mouth.Effect: removing heat from blood moves back steaming, eliminating heat from the lung.
Cornu Saigae Tataricae powder: phosphoric acid calcium, keratin and insoluble inorganic salt etc.Cold in nature, salty in the mouth.Effect: suppressing the hyperactive liver to relieve the wind syndrome.Liver heat removing and eyesight improving, heat-clearing and toxic substances removing.
Medicine dosage of the present invention is:
Radix Codonopsis 30g, Herba Crotalariae sessiliflorae 30g, Spina Gleditsiae 30g, Radix Angelicae Sinensis 15g, Indigo Naturalis 30g, Olibanum 15g, Myrrha 15g, Radix Trichosanthis 30g, Flos Lonicerae 30g, Rhizoma Anemarrhenae 30g, Cortex Lycii 30g, Cornu Saigae Tataricae powder 30g.
The present invention has: nourishing YIN to lower pathogenic fire, removes function such as bone marrow excess-heat, is applicable to that leukemia causes that leukocyte increases disease, and evident in efficacy through clinical verification for many years, be subjected to the consistent favorable comment of extensive patients.
Preparation method of the present invention is as follows:
With what select for use: Radix Codonopsis 30g, Herba Crotalariae sessiliflorae 30g, Spina Gleditsiae 30g, Radix Angelicae Sinensis 15g, Indigo Naturalis 30g, Olibanum 15g, Myrrha 15g, Radix Trichosanthis 30g, Flos Lonicerae 30g, Rhizoma Anemarrhenae 30g, Cortex Lycii 30g, several dosage of Cornu Saigae Tataricae powder 30g place in the rustless steel container and decoct, remove slag behind 2-3 the extracting juice, fry in shallow oil again.Extract and concentrate elite.Specification 200ml/ bottle.
The present invention aspect clinical efficacy, acute lymphoblastic leukemia (L wherein
1～L
3Type) effective remission rate 83%, rate 50% more, anxious non-pouring leukemia (M
1～M
7Type), effective remission rate 80%, cure rate 35%.
Preparation instructions of taking of the present invention: oral, every day twice, each one bottle.
Model case:
1, Feng Jing comes, man, 43 years old, people from Yingyang, Henan, chronic myelocytic leukemia, on October 20th, 2002, leukocyte 2.5 ten thousand/mm during first visit
3, to take medicine 20 days, the conventional leukocyte of blood test is reduced to 0.9 ten thousand/mm
3(normally).Other hemogram still can, subjective symptoms disappears substantially, continues to take medicine, hemogram was still alleviated in normal range after one month, indirectly progressively prolonged medicine time, periodic review chemical examination hemogram is followed the tracks of and is paid a return visit, and does not see recurrence.
2, Lee, the man, 63 years old, Henan Province Archives Administration, chronic myelocytic leukemia, nineteen eighty-two first visit on November 8, through the report of river doctor bone marrow aspiration, middle metamyelocyte accounts for 98%, and the nucleated cell active proliferation is made a definite diagnosis and is met slow grain leukemia, surrounding hemogram leukocyte 230,000/mm
3Took medicine 8 days, in chemical examination on November 16 nineteen eighty-two, leukocyte 1.57 ten thousand/mm
3, continue to take medicine, in chemical examination on November 23 nineteen eighty-two, leukocyte 7400/mm
3(normally), it is normal to have a meal, and body temperature is normal, and defecation is all normal, other transference cures, drug withdrawal is alleviated in after treatment to 1984 year April.
3, Gong Rongzao, the man, 46 years old, three workers of company were transported in Xuzhou, eosinophilia's property leukemia, symptom during on October 19th, 1989 first visit, tachycardia, the time headache is arranged, scorching on one's body gargalesthesia was deposited paint with under the external crucible.Often the low grade fever is 37.5 ℃～38 ℃.Hepatosplenomegaly, gastric acid, poor appetite, abdominal distention, swelling around the eyes, it is weak to pant, and dizzy insomnia is done the bone marrow aspiration inspection on July 24th, 1988 to hospital, makes a definite diagnosis sick for this reason chemical examination.Routine blood test hematochrome 3g, acidophilia (E) 57% takes medicine and chemically examines to October 15 nineteen ninety: hematochrome 11g, neutrality 50%, lymph 46%, platelet 120,000/mm
3, acidophil 2%.Alleviate recovery from illness fully.
Claims (3)
1, fall protamine oral liquor, it is characterized in that: it is to be prepared from by: Radix Codonopsis, dense lucky, Spina Gleditsiae, Radix Angelicae Sinensis, Indigo Naturalis, Olibanum, Myrrha, Radix Trichosanthis, Flos Lonicerae, the Rhizoma Anemarrhenae, Cortex Lycii, Cornu Saigae Tataricae powder.
2, the protamine oral liquor that falls according to claim 1 is characterized in that its medicine dosage is:
Radix Codonopsis 30g, Herba Crotalariae sessiliflorae 30g, Spina Gleditsiae 30g, Radix Angelicae Sinensis 15g, Indigo Naturalis 30g, Olibanum 15g, Myrrha 15g, Radix Trichosanthis 30g, Flos Lonicerae 30g, Rhizoma Anemarrhenae 30g, Cortex Lycii 30g, Cornu Saigae Tataricae powder 30g.
3, preparation method of falling protamine oral liquor according to claim 1, it is characterized in that: will select for use: Radix Codonopsis 30g, Herba Crotalariae sessiliflorae 30g, Spina Gleditsiae 30g, Radix Angelicae Sinensis 15g, Indigo Naturalis 30g, Olibanum 15g, Myrrha 15g, Radix Trichosanthis 30g, Flos Lonicerae 30g, Rhizoma Anemarrhenae 30g, Cortex Lycii 30g, several dosage of Cornu Saigae Tataricae powder 30g place in the rustless steel container and decoct, remove slag behind 2-3 the extracting juice, fry in shallow oil again.Extract and concentrate elite.Specification 200ml/ bottle.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410050165 CN1586506A (en) | 2004-06-29 | 2004-06-29 | Jiangbai oral liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410050165 CN1586506A (en) | 2004-06-29 | 2004-06-29 | Jiangbai oral liquid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1586506A true CN1586506A (en) | 2005-03-02 |
Family
ID=34602184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410050165 Pending CN1586506A (en) | 2004-06-29 | 2004-06-29 | Jiangbai oral liquid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1586506A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190160128A1 (en) | 2015-04-09 | 2019-05-30 | Galderma S.A. | Pharmaceutical composition comprising refined indigo naturalis extracts and the use thereof |
| US10668120B2 (en) | 2015-04-09 | 2020-06-02 | Galderma Sa | Antibacterial indigo naturalis or indigo-producing plant extract and use thereof |
| US10695391B2 (en) | 2015-04-09 | 2020-06-30 | Galderma S.A. | Extract from Indigo Naturalis and a process for preparing the same |
-
2004
- 2004-06-29 CN CN 200410050165 patent/CN1586506A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190160128A1 (en) | 2015-04-09 | 2019-05-30 | Galderma S.A. | Pharmaceutical composition comprising refined indigo naturalis extracts and the use thereof |
| US10555985B2 (en) | 2015-04-09 | 2020-02-11 | Galderma S.A. | Pharmaceutical composition comprising refined Indigo naturalis extracts and the use thereof |
| US10668120B2 (en) | 2015-04-09 | 2020-06-02 | Galderma Sa | Antibacterial indigo naturalis or indigo-producing plant extract and use thereof |
| US10695391B2 (en) | 2015-04-09 | 2020-06-30 | Galderma S.A. | Extract from Indigo Naturalis and a process for preparing the same |
| US11116811B2 (en) | 2015-04-09 | 2021-09-14 | Galderma S.A. | Pharmaceutical composition comprising refined indigo naturalis extracts and the use thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103386008B (en) | Chinese medicine composition for treating endocrine dyscrasia | |
| CN103495040B (en) | Traditional Chinese medicine composition for treating reflux esophagitis and preparation method of granule formulation thereof | |
| CN101422579B (en) | Traditional Chinese medicine preparation for treating oral ulcer | |
| CN104127531A (en) | Traditional Chinese medicine composition for treating enterogastritis and preparation method thereof | |
| CN103550687B (en) | A kind of Chinese medicine composition for the treatment of the hepatic and renal YIN deficiency | |
| CN103341127B (en) | Traditional Chinese medicine for treating uremia along with hematodialysis and preparation method | |
| CN102949553B (en) | Traditional Chinese medicine composition for treating superficial gastritis | |
| CN104758762A (en) | Traditional Chinese medicine composition for treating tuberculosis | |
| CN103550549B (en) | A kind of Chinese medicine composition for the treatment of deficiency of heart-yin | |
| CN103330854B (en) | Traditional Chinese medicine composition for treating nasal hemorrhage | |
| CN1586506A (en) | Jiangbai oral liquid | |
| CN104771509A (en) | Traditional Chinese medicine composition for treating migraine | |
| CN104547836A (en) | Traditional Chinese medicine composition for treating senile dementia | |
| CN104606523A (en) | Traditional Chinese medicine composition treating children's measles | |
| CN1151824C (en) | Oral liquid medicine for treating cough and asthma and preparation method thereof | |
| CN105250858A (en) | Traditional Chinese medicine composition for treating atrophic gastritis | |
| CN104606471A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN104771657A (en) | Traditional Chinese medicine composition for treating gastric ulcer | |
| CN103028058B (en) | Traditional Chinese medicine composition for treating feebleness | |
| CN104740405B (en) | A kind of Chinese medicine preparation and preparation method for treating anaphylactoid purpura renal damage | |
| CN1284593C (en) | Medicine for treating anaphylactoid purpura | |
| CN103751688B (en) | A kind of Chinese herbal medicine for the treatment of gastropathy and preparation method thereof | |
| CN105797044A (en) | Traditional Chinese medicinal composition for treating gastric ulcer | |
| CN107029055A (en) | For treating the leukemogenic compound Chinese medicinal preparation of liver warm blood stasis of blood institute and preparation method | |
| CN104825919B (en) | A kind of herb liquid for treating AIDS fever |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |